Pseudohypoparathyroidism a Case Report, With Studies on the Pathogenesis of the Condition

References

• Nagant de Deuxchaisnes C. Krane S.M. Hy poparathyroidism. In: Avioli LV, Krane SM. eds. Metabolic Bone Disease. Vol. II. New York: Academic Press, 1978: 217–445.
   Google Scholar
• Spiegel AM, Levine MA, Marx SJ, Aurbach GD. Pseudohypoparathyroidism: the molecular basis for hormone resistance. A retrospec tive. N Eng J Med. 1982; 307: 679–81.
   Google Scholar
• Leading Article. Pseudohypoparathyroidism: continuing paradox. Lancet. 1983; 2: 439 40.
   Google Scholar
• Nagant de Deuxchaisnes C, Fischer JA, Dambacher MA et al. Dissociation of parathyroid hormone bioactivity and immunoactivity in pseudohypoparathyroidism type I. J Clin En docrinol Metab. 1981; 53: 1105–9.
   Google Scholar
• Loveridge N, Fischer JA, Nagant de Deuxchaisnes C et al. Inhibition of cytocheinical bioactivity of parathyroid hormone by plasma in pseudohypoparathyroidism type 1. J Clin Endocrinol Metab. 1982; 54: 1274–5.
   Google Scholar
• Nagant de Deuxchaisnes C, Devogelaer JP, Docquier C, Crabbe J. Physiopathologie du pseudohypoparathyroi’disme. Ann Endocrinol (Paris). 1979; 40: 159–60.
   Google Scholar
• Nagant de Deuxchaisnes C, Rombouts-Lindemans C, Huaux JP, Withofs H, Meersseman F. Healing of vitamin D-deficient osteomalacia by the administration of 1,25 (OH)2D3. In: Maclntyre I, Szelke M. eds. Molecular Endocrinology. Amsterdam: Elsevier/North-Holland Biomedical Press. 1979: 375–404.
   Google Scholar
• Jiippner H, Bialasiewicz AA, Hesch RD. Autoantibodies to parathyroid hormone receptor. Lancet. 1978; 2: 1222–4.
   Google Scholar
• Nagant de Deuxchaisnes C, Rombouts-Lindemans C, Huaux JP, Devogelaer JP. Testing for hypoparathyroidism. N Engl J Med. 1979; 300: 140.
   Google Scholar
• Chase LR, Melson GL, Aurbach GD. Pseudohypoparathyroidism: defective excretion of 3’-5’-AMP in response to parathyroid hormone. J Clin Invest. 1969; 48: 1832–44.
   Google Scholar
• Meunier P, Edouard C, Courpron P, Toussaint F. Morphometric analysis of osteoid in iliac trabecular bone. Methodology. Dynamical significance of the osteoid parameters. In: Norman AW, Schaefer K, Grigoleit HG, von Herrath D, Ritz E. eds. Vitamin D and Problems Related to Uremic Bone Disease. Berlin: Walter de Gruyter. 1975: 149–55.
   Google Scholar
• Merz WA, Schenk RK. A quantitative histological study on bone formation in human cancellous bone. Acta Anat. (Basel). 1970; 76: 1–15.
   Google Scholar
• Kolb FO, Steinbach HL. Pseudohypoparathyroidism with secondary hyperparathyroidism and osteitis fibrosa. J Clin Endocrinol Metab 1962; 22: 59–70.
   Google Scholar
• Frame B, Hanson CA, Frost HM, Block M, Arnstein AR. Renal resistance to parathyroid hormone with osteitis fibrosa. «Pseudohypohyperparathyroidism». Am J Med. 1972; 52: 311–21.
   Google Scholar
• Dancaster CP, Schendel HE, Jackson WPU. Response to prolonged intramuscular administration of parathyroid hormone in the normal subject. Clin Sci. 1960; 19: 563–76.
   Google Scholar
• Zisman E, Lotz M, Jenkins ME, Bartter FC. Studies in pseudohypoparathyroidism. Two new cases with a probable selective deficiency of thyrotropin. Am J Med. 1969; 46: 46471.
   Google Scholar
• Birkenhager JC, Seldenrath HJ, Hackeng WHL, Schellekens APM, van der Veer ALJ, Roelfsema F. Calcium and phosphorus metabolism, parathyroid hormone, calcitonin and bone, histology in pseudohypoparathyroidism. Eur J Clin Invest. 1973; 3: 27–34.
   Google Scholar
• Suh SM, Fraser D, Kooh SW. Pseudohypoparathyroidism: responsiveness to parathyroid extract induced by vitamin D2 therapy. J CUn Endocrinol Metab. 1970; 30: 609–14.
   Google Scholar
• Stogmann W, Fischer JA. Pseudohypoparathyroidism. Disappearance of the resistance to parathyroid extract during treatment with vitamin D. Am J Med. 1975; 59: 140–4.
   Google Scholar
• Drezner MK, Neelon FA, Haussler M, McPherson HT, Lebovitz HE. 1, 25-dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism. J Clin Endocrinol Metab. 1976; 42: 621–8.
   Google Scholar
• Peacock M., Robertson WG, Nordin BEC. Relation between serum and urinary calcium with particular reference to parathyroid activity. Lancet. 1969; 1: 384–6.
   Google Scholar
• Litvak J, Moldawer MC, Forbes AP, Henneman PH. Hypocalcemic hypercalciuria during vitamin D and dihydrotachysterol therapy of hypoparathyroidism. J Clin Endocrinol Metab. 1958; 18: 246–52.
   Google Scholar
• Forbes AP. Donnees recentes sur le pseudohypoparathyroi’disme. Probl. Actuels Endocrinol Nutr. 1962; 6: 111–40.
   Google Scholar
• Carlson HE, Brickman AS, Bottazzo GF. Prolactin deficiency in pseudohypoparathyroidism. N Engl J Med. 1977; 296: 140–4.
   Google Scholar
• Usman A. Lack of effect of chronic hypocalcaemia on serum prolactin response to chlorpromazine. Acta Endocrinol. (Kbit.). 1983; 103: 321–5.
   Google Scholar
• Werder EA, Illig R., Bernasconi S. et al. Excessive thyrotropin response to thyrotropinreleasing hormone in pseudohypoparathyroidism. Pediatr. Res. 1975;9: 12–6.
   Google Scholar
• Rubinger D, Korn-Lubetzki I, Feldman S, Popovtzer MM. Delayed response to \<rhydroxycholecalciferol therapy in a case of pseudohypoparathyroidism during anticonvulsant therapy. Isr J Med Sci. 1980; 16: 772–4.
   Google Scholar
• Steendijk R. Prolonged treatment with vitamin D. N Engl J Med. 1978; 299: 554.
   Google Scholar
• Bronsky D, Kushner DS, Dubin A, Snapper I. Idiopathic hypoparathyroidism and pseudohypoparathyroidism: case reports and review of the literature. Medicine (Baltimore). 1958; 37: 317–52.
   Google Scholar
• Coulson R, Moses AM. Effect of chlorpropamide on renal response to parathyroid hormone in normal subjects and in patients with hypoparathyroidism and pseudohypoparathyroidism. J Pharmacol Exp Ther. 1975; 194: 603–13.
   Google Scholar
• Chambers DJ, Dunham J, Zanelli JM, Parsons JA, Bitensky L, Chayen J. A sensitive bioassay of parathyroid hormone in plasma. Clin Endocrinol. (Oxf.) 1978; 9: 375–9.
   Google Scholar
• Mosekilde L, Hansen HH, Christensen MS et al. Fractional intestinal calcium absorption in epileptics on anticonvulsant therapy. Acta Med Scand. 1979; 205: 405–9.
   Google Scholar
• Albright F, Burnett CH, Smith PH, Parson W. Pseudo hypoparathyroidism—an example of « Seabright-Bantam syndrome ». Endocrinology. 1942; 30: 922–32.
   Google Scholar
• Farfel Z, Brickman AS, Kaslow HR, Brothers-VM, Bourne HR. Defect of receptor-cyclase coupling protein in pseudohypoparathyroidism. N Engl J Med. 1980; 303: 237–42.
   Google Scholar
• Levine MA, Downs RW Jr, Singer M, Marx SJ, Aurbach GD, Spiegel AM. Deficient activity of guanine nucleotide regulatory protein in erythrocytes from patients with pseudohypoparathyroidism. /iiochem Biophvs Res Comm 1980; 94: 1319 24.
   Google Scholar
• Fischer J A. Bourne HR, Dambacher MA ct al. Pseudohypoparathyroidism: inheritance and expression of deficient receptor-cyclase coupling protein activity. Clin Endocrinol. (Oxi) 1983; 19: 747–54.
   Google Scholar
• Bouillon R, De Moor P. Development and applications of a radioimmunoassay for 1, 25-dihydroxyvitamin D. Acta Rhumatol. 1980; 4 • 373–8.
   Google Scholar